At any given time, investigators are conducting hundreds of trials. If you’re eligible to take part, you may have access to new options that aren’t widely available elsewhere.
Through melanoma research, enormous strides have been made in treating melanoma, dramatically improving the chance for survival and a high quality of life for many people with the disease. Many patients choose to take part in these studies.
As a result of clinical trial findings, there have been major treatment advances in two areas in particular: the development of immunotherapies that boost your immune system’s ability to fight cancer, such as ipilimumab (Yervoy™), and targeted therapies that hone in on specific defects in your individual cancer, blocking the growth of cancer cells while sparing most normal, healthy cells.
